02:21 PM EDT, 09/30/2024 (MT Newswires) -- Annovis Bio ( ANVS ) said Monday it filed three new patents for combination therapies involving its lead compound buntanetap with Trulicity or Viagra, or both.

The therapies aim to treat neurodegenerative diseases, including Alzheimer's and Parkinson's, the company said, adding that early data shows potential cognitive improvement in preclinical studies using these combinations.

Price: 8.06, Change: -0.04, Percent Change: -0.49